Meiko Hashimoto Maeda

1.2k total citations
34 papers, 640 citations indexed

About

Meiko Hashimoto Maeda is a scholar working on Molecular Biology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Meiko Hashimoto Maeda has authored 34 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Epidemiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Meiko Hashimoto Maeda's work include Inflammatory Myopathies and Dermatomyositis (10 papers), Genetic Neurodegenerative Diseases (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Meiko Hashimoto Maeda is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (10 papers), Genetic Neurodegenerative Diseases (5 papers) and DNA and Nucleic Acid Chemistry (4 papers). Meiko Hashimoto Maeda collaborates with scholars based in Japan, United States and Taiwan. Meiko Hashimoto Maeda's co-authors include Jun Shimizu, Shoji Tsuji, Yoshiyuki Kawazoe, T Uede, S Kon, Akihiro Imada, Noriharu Shijubo, Shinichi Abe, Toshiaki Segawa and Takuji Tanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Hepatology.

In The Last Decade

Meiko Hashimoto Maeda

28 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiko Hashimoto Maeda Japan 13 256 171 147 88 71 34 640
Zheng Cui United States 15 350 1.4× 132 0.8× 123 0.8× 161 1.8× 14 0.2× 31 885
Chunshu Yang China 22 749 2.9× 90 0.5× 144 1.0× 48 0.5× 320 4.5× 46 1.3k
Uttam Pati India 23 641 2.5× 107 0.6× 43 0.3× 251 2.9× 96 1.4× 40 1.1k
Kimio Kariya Japan 14 317 1.2× 30 0.2× 61 0.4× 38 0.4× 38 0.5× 48 734
Α. Φωτίου United Kingdom 14 339 1.3× 53 0.3× 26 0.2× 208 2.4× 40 0.6× 23 755
Claire Quiney France 14 533 2.1× 50 0.3× 28 0.2× 147 1.7× 87 1.2× 20 1.1k
Maciej Małecki Poland 14 280 1.1× 42 0.2× 16 0.1× 97 1.1× 67 0.9× 83 732
Pui–Kei Wu United States 17 672 2.6× 111 0.6× 32 0.2× 142 1.6× 32 0.5× 28 909
Danfeng Xue China 10 367 1.4× 148 0.9× 41 0.3× 117 1.3× 29 0.4× 15 604
Shan Zhao China 14 368 1.4× 105 0.6× 26 0.2× 90 1.0× 14 0.2× 43 705

Countries citing papers authored by Meiko Hashimoto Maeda

Since Specialization
Citations

This map shows the geographic impact of Meiko Hashimoto Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiko Hashimoto Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiko Hashimoto Maeda more than expected).

Fields of papers citing papers by Meiko Hashimoto Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiko Hashimoto Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiko Hashimoto Maeda. The network helps show where Meiko Hashimoto Maeda may publish in the future.

Co-authorship network of co-authors of Meiko Hashimoto Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Meiko Hashimoto Maeda. A scholar is included among the top collaborators of Meiko Hashimoto Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiko Hashimoto Maeda. Meiko Hashimoto Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matsukawa, Takashi, Yasufumi Hayashi, Akihiko Mitsutake, et al.. (2025). Vanishing White Matter Disease With EIF2B2 c.254T >A Variant. Neurology Genetics. 11(5). e200293–e200293.
3.
Takahashi, H., Ryochi Yoshida, M Nakano, et al.. (2024). Age-associated CD4 + T cells with B cell–promoting functions are regulated by ZEB2 in autoimmunity. Science Immunology. 9(93). eadk1643–eadk1643. 21 indexed citations
4.
Hashimoto, Kenichi, Ryochi Yoshida, Akatsuki Kubota, et al.. (2024). Severe finger necrosis in antisynthetase syndrome with positive anti‐OJ antibodies. SHILAP Revista de lepidopterología. 12(6). e8990–e8990.
5.
Kubota, Akatsuki, Meiko Hashimoto Maeda, Takashi Matsukawa, et al.. (2024). A Patient with Calpainopathy Carrying Compound Heterozygous Mutations of a <i>De Novo</i> Pathogenic Variant of c.1333G>A and a Novel Variant of c.1331C>T in <i>CAPN3</i>. Internal Medicine. 63(22). 3083–3086.
6.
Maeda, Meiko Hashimoto, Takuya Kawahara, Akatsuki Kubota, Jun Shimizu, & Tatsushi Toda. (2024). Prevalence and risk surveillance of anti-mitochondrial antibody-positive myositis: Outcomes of a nationwide survey. Journal of the Neurological Sciences. 467. 123287–123287. 4 indexed citations
7.
Maeda, Meiko Hashimoto, Hiroyuki Ishiura, Yuichiro Shirota, et al.. (2024). Subacute Upper Motor Neuron Dysfunction Possibly Associated with the Anti-GM1 Autoantibody. Internal Medicine. 64(12). 1900–1905. 2 indexed citations
8.
Matsumoto, Yusuke, Kentaro Kojima, Nobuo Toda, et al.. (2023). Anti‐nuclear matrix protein 2 antibody‐positive dermatomyositis with gastrointestinal ulcers: A case report. International Journal of Rheumatic Diseases. 26(12). 2572–2575. 2 indexed citations
9.
Amiya, Eisuke, Meiko Hashimoto Maeda, Junichi Ishida, et al.. (2022). The Effect of Immunosuppressive Therapy on Cardiac Involvements in Anti-Mitochondrial Antibody-Positive Myositis. ESC Heart Failure. 9(6). 4112–4119. 6 indexed citations
10.
Komai, Toshihiko, Norio Hanata, Akatsuki Kubota, et al.. (2021). Anti-Ku antibody-positive myositis presenting as a wide range of axial myopathies and myocarditis: A case report and review of the literature. Modern Rheumatology Case Reports. 6(1). 64–68. 7 indexed citations
11.
Ikeda, Kensuke, Madoka Mori‐Yoshimura, Toshiyuki Yamamoto, et al.. (2016). Chronic Myopathy Associated With Anti–Signal Recognition Particle Antibodies Can Be Misdiagnosed As Facioscapulohumeral Muscular Dystrophy. Journal of Clinical Neuromuscular Disease. 17(4). 197–206. 15 indexed citations
12.
Nakamoto, Fumiko Kusunoki, et al.. (2014). Memory impairment following right cerebellar infarction: a case study. Neurocase. 21(5). 660–664. 8 indexed citations
13.
Saito, Rie, et al.. (2014). A case of 77-year-old male with spinocerebellar ataxia type 31 with left dominant dystonia. Rinsho Shinkeigaku. 54(8). 643–647. 2 indexed citations
14.
Maeda, Meiko Hashimoto, Shoji Tsuji, & Jun Shimizu. (2012). Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain. 135(6). 1767–1777. 94 indexed citations
15.
Maeda, Meiko Hashimoto, Jun Mitsui, Bing‐Wen Soong, et al.. (2011). Increased gene dosage of myelin protein zero causes Charcot‐Marie‐Tooth disease. Annals of Neurology. 71(1). 84–92. 25 indexed citations
16.
Shijubo, Noriharu, T Uede, S Kon, et al.. (1999). Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 160(4). 1269–1273. 96 indexed citations
17.
Maeda, Meiko Hashimoto, Tetsuya Suga, Nobuo Takasuka, Akio Hoshi, & Takamitsu Sasaki. (1990). Effect of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes on lung metastasis of B16-F10 melanoma cells in mice. Cancer Letters. 55(2). 143–147. 13 indexed citations
18.
Yamamura, Teiichi, et al.. (1984). Malignant fibrous histiocytoma developing in a burn scar. British Journal of Dermatology. 110(6). 725–730. 35 indexed citations
19.
Maeda, Meiko Hashimoto, et al.. (1976). Chemical alteration of nucleic acids and their components—XIII. Tetrahedron. 32(3). 337–340. 10 indexed citations
20.
Maeda, Meiko Hashimoto, Yukiko Iwase, & Masayasu Kojima. (1976). Photoalkylation of phenanthro[9,10‐d] oxazole. Journal of Heterocyclic Chemistry. 13(2). 221–223.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zheng Cui Breakdown of academic impact, for papers by Chunshu Yang Breakdown of academic impact, for papers by Uttam Pati Breakdown of academic impact, for papers by Kimio Kariya Breakdown of academic impact, for papers by Α. Φωτίου Breakdown of academic impact, for papers by Claire Quiney Breakdown of academic impact, for papers by Maciej Małecki Breakdown of academic impact, for papers by Pui–Kei Wu Breakdown of academic impact, for papers by Danfeng Xue Breakdown of academic impact, for papers by Shan Zhao
Rankless by CCL
2026